A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?

Maurer, M. S. (2025). A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression? Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.01.015
Authors:
Mathew S Maurer
Affiliated Authors:
Mathew S Maurer
Columbia Affiliation:
Author Keywords:
attr-cm
heart failure
therapies
transthyretin amyloid cardiomyopathy
transthyretin biology
elink
Publication Type:
Article
Unique ID:
10.1016/j.cardfail.2025.01.015
PMID:
39947423
DOI:
10.1016/j.cardfail.2025.01.015
Journal:
Journal of Cardiac Failure
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: